Data of relative mRNA and protein abundances of androgen receptor splice variants in castration-resistant prostate cancer

• Main Authors: Tianfang Ma, Nathan Ungerleider, Derek Y. Zhang, Eva Corey, Erik K. Flemington, Yan Dong
• Format: Article
• Language: English
• Published: Elsevier 2021-02-01
• Series: Data in Brief
• Subjects: Androgen receptor; Splice variants; Castration-resistant prostate cancer; Androgen deprivation therapy
• Online Access: http://www.sciencedirect.com/science/article/pii/S2352340921000585

These data include secondary analysis of publicly available RNA-seq data from castration-resistant prostate cancer (CRPC) patients as well as RT-qPCR and Western blotting analyses of patient-derived xenograft models and a CRPC cell line. We applied Spearman correlation analysis to assess the relationship between canonical androgen receptor (AR) splicing and alternative AR splicing. We also assessed the ratio of AR splice variants (AR-Vs) to the full-length AR (AR-FL) at the RNA and protein levels by absolute RT-qPCR and Western blotting, respectively. These data are critical for studying the mechanisms underlying upregulated expression of AR-Vs after AR-directed therapies and the importance of AR-Vs to castration-resistant progression of prostate cancer. Data presented here are related to the research article by Ma et al., “Increased transcription and high translation efficiency lead to accumulation of androgen receptor splice variant after androgen deprivation therapy”, Cancer Lett. In Press [1].